Format

Send to

Choose Destination
Cancer Res. 2019 Jun 1;79(11):2878-2891. doi: 10.1158/0008-5472.CAN-18-3369. Epub 2019 Apr 11.

A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.

Author information

1
Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland.
2
Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, Maryland.
3
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
4
Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland. konstant@jhu.edu.
5
Johns Hopkins Physical Sciences-Oncology Center, The Johns Hopkins University, Baltimore, Maryland.
6
Department of Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland.

Abstract

The sialoglycoprotein podocalyxin is absent in normal pancreas but is overexpressed in pancreatic cancer and is associated with poor clinical outcome. Here, we investigate the role of podocalyxin in migration and metastasis of pancreatic adenocarcinomas using SW1990 and Pa03c as cell models. Although ezrin is regarded as a cytoplasmic binding partner of podocalyxin that regulates actin polymerization via Rac1 or RhoA, we did not detect podocalyxin-ezrin association in pancreatic cancer cells. Moreover, depletion of podocalyxin did not alter actin dynamics or modulate Rac1 and RhoA activities in pancreatic cancer cells. Using mass spectrometry, bioinformatics analysis, coimmunoprecipitation, and pull-down assays, we discovered a novel, direct binding interaction between the cytoplasmic tail of podocalyxin and the large GTPase dynamin-2 at its GTPase, middle, and pleckstrin homology domains. This podocalyxin-dynamin-2 interaction regulated microtubule growth rate, which in turn modulated focal adhesion dynamics and ultimately promoted efficient pancreatic cancer cell migration via microtubule- and Src-dependent pathways. Depletion of podocalyxin in a hemispleen mouse model of pancreatic cancer diminished liver metastasis without altering primary tumor size. Collectively, these findings reveal a novel mechanism by which podocalyxin facilitates pancreatic cancer cell migration and metastasis. SIGNIFICANCE: These findings reveal that a novel interaction between podocalyxin and dynamin-2 promotes migration and metastasis of pancreatic cancer cells by regulating microtubule and focal adhesion dynamics.

PMID:
30975647
PMCID:
PMC6548656
[Available on 2020-06-01]
DOI:
10.1158/0008-5472.CAN-18-3369

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center